Skip to content
SSR-Health-CMYK-176x126
  • Home
  • About Us
    • Team
    • In the Media
    • In the Literature
  • Contact
  • Home
  • About Us
    • Team
    • In the Media
    • In the Literature
  • Contact
SSR-Health-CMYK-176x126
  • Home
  • About Us
    • Team
    • In the Media
    • In the Literature
  • Contact
  • Home
  • About Us
    • Team
    • In the Media
    • In the Literature
  • Contact

MRK: R&D Productivity, as Compared to Peers

  • Post author:Richard Evans
  • Post published:May 5, 2014
  • Post category:Embargoed/Major pharmaceuticals/R&D Productivity

Returns on R&D Spending are Low v. Peers Merck’s economic returns to R&D spending (an enterprise-wide measure of R&D productivity that compares yr1 R&D spending to yr10 adjusted earnings)[i] exceeded…

Continue ReadingMRK: R&D Productivity, as Compared to Peers

MRK v. AMGN: A Comparison of R&D Productivity

  • Post author:Richard Evans
  • Post published:January 7, 2014
  • Post category:Biotechnology/Current/Major pharmaceuticals
  • Post comments:0 Comments

Summary and Conclusion In light of the recent change in MRK’s R&D leadership, and evidence[1] that the company may be planning a significant change in its approach to R&D, we…

Continue ReadingMRK v. AMGN: A Comparison of R&D Productivity

Contact Us

Twitter Linkedin

© Copyright 2025. SSR Health, LLC

Contact Us

Linkedin

© Copyright 2025. SSR Health, LLC